MILWAUKEE, Feb. 26, 2026 /PRNewswire/ — Ademi LLP is investigating possible securities fraud claims against PROCEPT BioRobotics (NASDAQ: PRCT). The investigation results from inaccurate statements PROCEPT BioRobotics may have made regarding its financial statements, business operations and prospects.
Click here to join our investigation or to obtain additional information, or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you.
The investigation focuses on whether PROCEPT BioRobotics’ disclosures with respect to the sales processes and inventory of its disposable handpieces used with its aquablation technology were accurate. Significant portions of the sales of such handpieces were depended upon quarter end promotional discounts, which PROCEPT BioRobotics has discontinued. As a result, PROCEPT BioRobotics has reported quarterly revenue 19% below forecasts and annual sales guidance for 2026 of 5% below expectations.
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Ademi LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001
www.ademilaw.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ademi-llp-investigates-claims-of-securities-fraud-against-procept-biorobotics-corporation-302698907.html
SOURCE Ademi LLP
